First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus

✍ Scribed by Anita Kapur, Robin O’Connor-Semmes, Elizabeth K Hussey…

• Book ID: 120890406
• Publisher: Springer (Biomed Central Ltd.)
• Year: 2013
• Tongue: English
• Weight: 270 KB
• Volume: 14
• Category: Article
• ISSN: 2050-6511
• DOI: 10.1186/2050-6511-14-26